Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years
在≥50岁的成年人中,接种mRNA-1345(一种针对呼吸道合胞病毒的mRNA疫苗)12个月后再次接种的安全性、耐受性和免疫原性
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciaf515
Goswami, Jaya; Cardona, Jose F; Caso, Jorge; Hsu, Denise C; Simorellis, Alana K; Wilson, Lauren; Dhar, Rakesh; Wang, Xiaowei; Kapoor, Archana; Collins, Avi; Righi, Vinicius; Lan, Lan; Du, Jiejun; Zhou, Honghong; Stoszek, Sonia K; Shaw, Christine A; Reuter, Caroline; Wilson, Eleanor; Das, Rituparna